Cancer‐related mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery
Surgery may leads to lower cancer‐related mortality at maximal compared with radiofrequency ablation (low certainty).
1 finding from 1 review
Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery
Surgery may leads to higher serious adverse events (number of participants) compared with radiofrequency ablation (low certainty).
1 finding from 1 review
Serious adverse events (number of events) · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery
Surgery may leads to higher serious adverse events (number of events) compared with radiofrequency ablation (low certainty).
1 finding from 1 review
Health‐related quality of life · people with early‐ or very early‐stage hepatocellular carcinoma eligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain (VAS) from 0 to 10, 0 is no pain · people with full‐thickness rotator cuff tears
1 finding from 1 review
Functional outcomes · people with full‐thickness rotator cuff tears
1 finding from 1 review
Global assessment of treatment success · people with full‐thickness rotator cuff tears
Surgery showed no clear difference in participant‐rated global assessment of treatment success at 12 months compared with non‐operative treatment (low certainty).
1 finding from 1 review
Health‐related quality of life (mental) · people with full‐thickness rotator cuff tears
1 finding from 1 review
Adverse events · people with full‐thickness rotator cuff tears
1 finding from 1 review
Serious adverse events · people with full‐thickness rotator cuff tears
1 finding from 1 review
Control of bleeding (cure or improvement to acceptable level) At 2 years · women with heavy menstrual bleeding
Surgery probably leads to higher control of bleeding (cure or improvement to acceptable level) At 4… compared with oral medication (moderate certainty).
3 findings from 1 review
RR 2.66 [1.94, 3.64]
1 study · 186 participants
Moderate
RR 1.29 [1.06, 1.57]
1 study · 173 participants
Low
RR 1.14 [0.97, 1.34]
1 study · 140 participants
Very low
Proportion of women with adverse events Endometrial ablation versus LNG‐IUS. At one year · women with heavy menstrual bleeding
Surgery probably leads to lower proportion of women with adverse events Endometrial ablation versus… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Overall satisfaction with treatment At 2 years · women with heavy menstrual bleeding
Surgery probably leads to higher overall satisfaction with treatment At 2 years compared with oral medication (moderate certainty).
1 finding from 1 review
Overall satisfaction with treatment At 5 years · women with heavy menstrual bleeding
It is very uncertain whether surgery changes overall satisfaction with treatment At 5 years compared with oral medication (very low certainty).
1 finding from 1 review
Adverse events at 4 months · women with heavy menstrual bleeding
Surgery probably leads to lower adverse events at 4 months compared with oral medication (moderate certainty).
1 finding from 1 review
Objective control of bleeding: menstrual loss under 80 ml per cycle LNG‐IUS versus hysterectomy At 1 year · women with heavy menstrual bleeding
Surgery probably leads to higher objective control of bleeding: menstrual loss under 80 ml per cycle… compared with LNG‐IUS (moderate certainty).
1 finding from 1 review
Subjective control of bleeding: PBAC no more than 75 per cycle Endometrial resection or ablation versus LNG‐IUS At 1 year · women with heavy menstrual bleeding
Surgery may leads to higher subjective control of bleeding: PBAC no more than 75 per cycle… compared with LNG‐IUS (low certainty).
1 finding from 1 review
Survival ‐ overall · Women (70 years plus) with operable primary breast cancer
Surgery showed no clear difference in survival ‐ overall compared with primary endocrine therapy (low certainty).
1 finding from 1 review
Patient‐reported outcome measures (PROMs) · people with age‐related cataract
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
1‐Year radiosurgery‐targeted lesion controlNo. of participants: 602(4 RCTs) · patients with newly diagnosed multiple brain metastases
Radiosurgery alone leads to higher 1‐Year radiosurgery‐targeted lesion controlNo. of participants:… compared with WBRT and radiosurgery (high certainty).
1 finding from 1 review
HR 2.73 [1.87, 3.99]
Studies not reported
High